Alkermes

Alkermes appears in Wake-up haul: an Ozempic moment for the brain as one of the companies working on orexin-agonist drugs. The source groups it with Takeda Pharmaceutical / 武田制药 and Eli Lilly inside a potential new drug-category race.

The episode does not provide detailed trial data for Alkermes. Its wiki role is therefore limited to the competitive signal: multiple companies are exploring orexin as a wakefulness and neuropsychiatric drug target beyond the initial narcolepsy use case.

Connections

• Orexin Agonists and Narcolepsy Wake-Sleep Boundary - drug-category and use-case context.
• Takeda Pharmaceutical / 武田制药, Eli Lilly, and Sentessa Pharmaceuticals - other companies named in the orexin segment.
• Shailesh Chitnis - segment explainer.